Market Access
A strategic approach to local affiliates in the global era
While global harmonisation remains the holy grail, the reality is …
19771 items found
News
BMS chases MSD/Seagen with first-line bladder cancer filing
The FDA has started a priority review of Bristol-Myers Squibb Opdivo …
Digital
Creating a future where the healthcare ecosystem works for everyone
In a new episode of the pharmaphorum podcast, web editor Nicole …
News
Roche bounces back in PIK3 with inavolisib data
A few years ago, Roche abandoned the development of its lead …
Oncology
Reinvigorating the Cancer Moonshot with empowered patients
The Biden administration has made various organisational and …
News
Pharma accuses UK of ‘mixed messages’ on rebate schemes
The pharma industry and the UK government may have reached an accord …
News
Alto hits a high note with AI-driven depression therapy
Alto Neuroscience has said its therapeutic approach to depression of …
News
Seismic shakes up $121m for AI-designed immunology drugs
Seismic Therapeutics has raised $121 million in second-round …
News
Merck grabs late-stage oncology drug from China’s Abbisko
Germany’s Merck KGaA is paying Chinese biotech Abbisko Therapeutics …
Oncology
Uveal melanoma: A new generation of therapies offers hope for patients
The summer of 2023 saw the approval of a new treatment option for …
News
UK primary care group adopts digital heart failure pathway
A digital approach to the care of patients with heart failure, …
News
Pfizer drops twice-daily obesity therapy due to side effects
Pfizer has decided to discontinue the development of another of its …
News
Eisai, Biogen eye 2025 approval for Leqembi autoinjector
Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
